The Capital Map: When Strong Companies Take the Wrong Line
How founders misread the signals that unlock capital.
Most companies that struggle to raise capital aren’t failing but are often misrouted.
They’re on the wrong line, approaching the wrong stations, or missing the interchange moments that matter. And the reason isn’t a lack of ambition or quality, but a mismatch between how founders understand capital and how the system actually behaves.
The room brings together founders building in AI, life sciences, deeptech, climate and emerging technologies, alongside investors actively involved in early and growth-stage capital decisions.
This session builds on The Capital Map, sclr labs’ ongoing work examining how capital actually moves — and the structural signals (from IP and governance to narrative and timing) that determine when companies become investable.
This session examines the assumptions founders and investors hold about how capital actually moves — and where they break down in practice.
What we’ll explore
Why founders often target the wrong capital line and stay on it too long
The signals founders misread when deciding who to raise from
Interchange moments: when a company genuinely becomes investable to a different type of capital
Why strong companies still stall.
Featuring:
Lina Mikolajczyk - Chief AI and Data Officer at Venatus, focused on turning AI into measurable revenue uplift through optimization, forecasting and automation. She previously led Data, Machine Learning and AI teams at Bumble, Dojo, Moo.com, and Hilton, focusing on monetizing data to drive growth.
Soma Pirityi - works as a venture capitalist, partnering with early‑stage teams where his experience as both investor and founder helps change the trajectory of company's. His background working on dozens of VC transactions, combined with building ETA Technologies for institutional investors, means he approaches every deals with a deep understanding of both fund economics and founder reality.
Hunter Moore - focusing on backing the next generation of AI-driven healthcare companies. Hunter joined SVV in 2025 from Monogram Health, one of the fastest-growing private healthcare companies in the US, bringing experience across early-stage startups, high-growth private companies and private equity funds, with a strong focus on improving healthcare quality, access and patient experience.
Timothy Leeson - leading the Corporate Finance practice at Lewis Silkin, advising founders, growth companies, investors and financial institutions on financing rounds, M&A and IPOs. With more than 30 years’ experience in the technology sector and an international practice spanning the US, Middle East and Asia-Pacific, he works with both disruptive businesses and the institutions they challenge. He is a trusted adviser who sits at the table when complex, cross-border deals are negotiated and closed.
Format:
A curated founder × investor conversation examining how capital actually moves — and how companies can position themselves more intelligently within that system.
Who should attend
Founders actively building and fundraising
Active investors involved in early and growth-stage decision-making
Attendance is by approval to protect the high level quality of the room.
Dress code: smart casual
📸 Event photography
By attending, you consent to being photographed and filmed for promotional use. If you'd prefer not to have your photos used or details shared, please let us know, and we’ll respect your preferences.
We look forward to seeing you at the session.
🚪Respect the Room
At sclr labs, we run on respect, for our speakers, for the founders who show up early, and for the momentum we’re building in the room.
When we say doors close at the start of the formal session, we mean it. Late arrivals miss context, break flow, and dilute energy. So plan ahead and show up on time.